Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-31
2009-08-18
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S125000
Reexamination Certificate
active
07576097
ABSTRACT:
The present invention provides compounds of the formula:wherein R1is C3-6cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6alkyl optionally substituted by one or more fluorine atoms, or C3-6cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; andR2is phenyl optionally substituted by one or more fluorine atoms,to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
REFERENCES:
patent: 5968947 (1999-10-01), Urch et al.
patent: 6586430 (2003-07-01), Armour et al.
patent: 6667314 (2003-12-01), Perros et al.
patent: 7368460 (2008-05-01), Perros et al.
patent: 0630887 (1994-05-01), None
patent: 0903349 (1998-08-01), None
patent: WO 9111172 (1991-08-01), None
patent: WO 9402518 (1994-02-01), None
patent: WO 9528401 (1995-10-01), None
patent: WO 9713770 (1997-04-01), None
patent: WO 9719060 (1997-05-01), None
patent: WO 9724325 (1997-07-01), None
patent: WO 9802151 (1998-01-01), None
patent: WO 9825604 (1998-06-01), None
patent: WO 9825617 (1998-06-01), None
patent: WO 9937617 (1998-06-01), None
patent: WO 9855148 (1998-12-01), None
patent: WO 9904794 (1999-02-01), None
patent: WO 9917773 (1999-04-01), None
patent: WO 9937619 (1999-07-01), None
patent: WO 0038680 (2000-07-01), None
Shimada et al., FEBS letters, (Apr. 3, 1998) vol. 425, No. 3, pp. 490-494.
Berge, et al., “Pharmaceutical Salts,” Journal of Pharmaceutical Science, 1977, 1-19, vol. 66., No. 1.
Cascieri, et al., “The Chemokine/Chemokine Receptor Family: Potential and Progress for Therapeutic Intervention,” Current Opinion Chem. Biol. 2000, 420-427, vol. 4, No. 4.
Combadiere, et al., “Cloning and Functional Expression of CC CKR5, a Human Monocyte CC Chemokine Receptor Selective for MIP-1α, MIP-1β, and RANTES,” Journal of Leukocyte Biology, 1996, 147-152, vol. 60.
Connor, et al., “VPR Is Required for Efficient Replication of Human Immunodeficiency Virus Type-1 in Mononuclear Phagocyte,” Virology, 1995, 935-944, vol. 206, No. 2.
Dimitrov, et al., Microculture Assay for Isolation of Human Immunodeficiency Virus Type 1 and Titration of Infected Peripheral Blood Mononuclear Cells, Journal of Clinical Microbiology, 1990, 734-737, vol. 28, No. 4.
Hesselgesser, J., et al., “Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor,” Journal of Biological Chemistry, 1998, 15687-15692, vol. 273, No. 25.
Choe, H ., et al., “The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection By Primary HIV-1 Isolates,” Cell, 1996, 1135-1148, vol. 85.
Fatkenheuer, G., et al., “Efficacy of Short-Term Monotherapy With Maravioron, A New CCR5 Antagonist, In Patients Infected With HIV,”Nature Medicine, 2005, 1170-1172, vol. 11, No. 11.
Littman, D., et al., “Chemokine Receptors: Keys to AIDS Pathogenesis?” Cell, 1998, 677-680, vol. 93.
Zhang, L., et al., “In Vivo Distribution of The Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5,” Journal of Virology, 1998, 5035-5045, vol. 72, No. 6.
Zhang, L., et al., “Chemokine Coreceptor Usage By Diverse Primary Isolates of Human Immunodeficiency Virus Type”, Journal of Virology, 1998, 9307-9312, vol. 72, No. 11.
Progenics Report Discovery of CCR5 Structure That Binds HIV—Advances Development of New Class of HIV Fusion Inhibitors, 2000, PRNewswire, Taos, New Mexico.
Perros Manoussos
Price David Anthony
Stammen Blanda Luzia Christa
Wood Anthony
Benson Gregg C.
Creagan B. Timothy
Pfizer Inc.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Tropane derivatives useful in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tropane derivatives useful in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tropane derivatives useful in therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4076517